1h Free Analyst Time
The structural heart disease treatment devices market is poised to grow by $7.60 bn during 2022-2026, accelerating at a CAGR of 10.03% during the forecast period. The report on the structural heart disease treatment devices market provides a holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of structural heart diseases, the rising number of new product launches, and the growing number of M&A activities.
The structural heart disease treatment devices market analysis includes the method segment and geographic landscape.
The structural heart disease treatment devices market is segmented as below:
By Method
- Replacement procedures
- Repair procedures
By Geographical Landscape
- North America
- Europe
- APAC
- ROW
The report on the structural heart disease treatment devices market covers the following areas:
- Structural heart disease treatment devices market sizing
- Structural heart disease treatment devices market forecast
- Structural heart disease treatment devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Method
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global structural heart disease treatment devices market: Abbott Laboratories, Becton, Dickinson and Co., Boston Scientific Corp., Braile Biomédica, CryoLife Inc., Edwards Lifesciences Corp., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova Plc, Medtronic Plc, and MicroPort Scientific Corp.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the growing number of strategic alliances.`
According to the report, one of the major drivers for this market is the increasing prevalence of structural heart diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Becton, Dickinson and Co.
- Boston Scientific Corp.
- Braile Biomédica
- CryoLife Inc.
- Edwards Lifesciences Corp.
- Lepu Medical Technology (Beijing) Co. Ltd.
- LivaNova Plc
- Medtronic Plc
- MicroPort Scientific Corp.
